Endlicher E, Völk M, Feuerbach S, Schölmerich J, Schäffler A, Messmann H
Department of Internal Medicine I, University of Regensburg, D-93042 Regensburg, Germany.
Hepatogastroenterology. 2003 Nov-Dec;50(54):2225-8.
BACKGROUND/AIMS: The objective of this follow-up study was to assess the long-term outcome of patients with infected necrotizing pancreatitis treated with percutaneous catheter drainage and necrosectomy.
Nine patients (median age 44 years, range 19-69) with infected pancreatic necrosis and catheter drainage for initial treatment were evaluated after a median follow-up of 30 months (range 15-52) with respect to quality of life (pain, diarrhea, fat intolerance), morphology and endocrine and exocrine pancreatic function.
At follow-up all 9 patients (100%) were in good general condition with respect to quality of life. Only 2/9 (22%) patients had moderate to marked changes in computed tomography. There was mild to moderate exocrine dysfunction in 5/8 (63%) patients, 2/8 (25%) patients had a severe restriction of the exocrine pancreatic function; in one patient the serum pancreoaryl test was normal. An oral glucose tolerance test was performed in 6/9 patients, with a normal result in 3/6 (50%) patients. 2/6 (33%) patients had an impaired oral glucose tolerance test with metabolic pathogenesis. One patient with diabetes in the oral glucose tolerance test had a preexisting type II diabetes requiring insulin therapy since the onset of acute pancreatitis. In 3/9 (33%) patients an oral glucose tolerance test was not performed due to known preexisting diabetes.
Percutaneous drainage of infected necrotizing pancreatitis has given good long-term results with regard to quality of life, endocrine and exocrine pancreatic function and may be an alternative to surgical treatment.
背景/目的:本随访研究的目的是评估经皮导管引流和坏死组织清除术治疗感染性坏死性胰腺炎患者的长期预后。
对9例(中位年龄44岁,范围19 - 69岁)因感染性胰腺坏死接受导管引流作为初始治疗的患者进行评估,中位随访30个月(范围15 - 52个月),评估内容包括生活质量(疼痛、腹泻、脂肪不耐受)、形态学以及胰腺内分泌和外分泌功能。
随访时,所有9例患者(100%)生活质量总体良好。仅2/9(22%)患者的计算机断层扫描有中度至明显变化。5/8(63%)患者存在轻度至中度外分泌功能障碍,2/8(25%)患者外分泌胰腺功能严重受限;1例患者血清胰酶检测正常。9例患者中的6例进行了口服葡萄糖耐量试验,其中3/6(50%)患者结果正常。2/6(33%)患者口服葡萄糖耐量试验受损且存在代谢发病机制。口服葡萄糖耐量试验中有1例糖尿病患者自急性胰腺炎发作以来就患有II型糖尿病,需要胰岛素治疗。9例患者中有3例(33%)因已知既往存在糖尿病未进行口服葡萄糖耐量试验。
经皮引流感染性坏死性胰腺炎在生活质量、胰腺内分泌和外分泌功能方面取得了良好的长期效果,可能是手术治疗的一种替代方法。